Varenicline tartrate - Smoking cessation
You are here : Home > Formulary Search > Varenicline tartrate - Smoking cessation
Documentation
PAD Profile
Other Indications
Below are listed other indications that Varenicline tartrate is used to treat.
- No records returned.
Committee Recommendations (1)
Referral of patients to a smoking cessation service is the preferred management pathway.
GPs should only prescribe smoking cessation products for patients who decline referral in line with CKS guidance or through requests from the smoking cessation service (see below).
The ‘One You Surrey’ Smoking cessation service has been commissioned by Public Health (Surrey County Council) since April 2019 and provides support to clients as part of a 12 week programme.
Nicotine replacement therapy (NRT) will be provided as part of the service in pregnancy and for clients with defined long-term health conditions.
Requests to prescribe NRT will only be made to the GP in rare circumstances where the client requests further NRT beyond 12- weeks (at the discretion of the GP).
For clients requiring the following, a request form for prescribing (includes screening questions) will be sent to the client’s GP by the service:
- Bupropion (Zyban)
- Varenicline
- Cytisinicline
Clients will be monitored by ‘One You’ Surrey on a weekly basis for any side effects. At the end of treatment, patients will be issued with a letter to be given to their GP to update records and book a medication review (where appropriate).
Patients can be referred by a health care professional or can self refer: https://oneyousurrey.org.uk/stop-smoking/
Further information on the service is available at: https://oneyousurrey.org.uk/
There is a dedicated section for primary care health professionals: https://oneyousurrey.org.uk/professionals/
Bupropion, Varenicline and Cytisinicline will be given a GREEN (see narrative) traffic light status on the Joint Formulary